HAPLN1 and gastric cancer: CAFs-derived HAPLN1 is associated with disease progression and poor prognosis in gastric cancer, and CAFs-derived HAPLN1 enhances gastric cancer cell invasiveness through extracellular matrix remodeling (Fig. 7).